"All or nothing" push on ATMP abandoned by European Parliament
This article was originally published in Clinica
Executive Summary
Miroslav Mikolasik, rapporteur at the European Parliament for the European Commission's proposed Advanced Therapy Medicinal Products Regulation, has terminated discussions between the European Commission, the European Parliament and the European Council aimed at reaching agreement on the text in a first reading.